- Home
-
The UCLM
-
Communication
-
News
-
Researchers at the U ..... multiple sclerosis
The scientific work has been published in the journal Proceedings of the National Academy of Sciences (USA)
Researchers at the UCLM discover an anti-inflammatory nanoparticle that could be used in diseases such as multiple sclerosis
27/09/2017
Share:
Researchers at the UCLM discover an anti-inflammatory nanoparticle that could be used in diseases such as multiple sclerosis
27/09/2017
The research group of the University of Castilla-La Mancha (UCLM) Neurodeath, headed by the professor of Pharmacology, Valentín Ceña, discovered the anti-inflammatory action of a new nanoparticle, a phosphorus dendrimer without electric charge, which has an anti-inflammatory action, both in cell cultures and in animal models of inflammation. This is something that, according to Professor Ceña, "provides a great therapeutic potential since it could be the basis for the development of new molecules with a potential therapeutic use in the treatment of inflammatory or autoimmune diseases, such as multiple sclerosis."
In this study, whose first signer is the professor of the UCLM Inmaculada Posadas, it is contemplated that, additionally, the chemical modification of the nanoparticle surface could endow it with new diagnostic and therapeutic properties.
The present work, recently published in the scientific journal Proceedings of the National Academy of Sciences of the United States, also counts with the collaboration of the graduates in Pharmacy of the Regional University Laura Romero and Darío Manzanares, as well as the participation of scientists from the French National Center for Scientific Research (CNRS), and the University of Madeira.
Gabinete de Comunicación UCLM. Albacete, September 25, 2017
Más actualidad